Back to Search Start Over

Non-phosphorylatable mutants of Ser184 lead to incomplete activation of Bax

Authors :
Lilit Simonyan
Mathilde Gonin
James Hanks
Jordan Friedlein
Kevin Dutrec
Hubert Arokium
Akandé Rouchidane Eyitayo
Toukounou Megann Doudy
Stéphane Chaignepain
Stéphen Manon
Laurent Dejean
Source :
Frontiers in Oncology, Vol 12 (2023)
Publication Year :
2023
Publisher :
Frontiers Media S.A., 2023.

Abstract

The S184 residue of Bax is the target of several protein kinases regulating cell fate, including AKT. It is well-established that, in cellulo, the substitution of S184 by a non-phosphorylatable residue stimulates both the mitochondrial localization of Bax, cytochrome c release, and apoptosis. However, in in vitro experiments, substituted mutants did not exhibit any increase in their binding capacity to isolated mitochondria or liposomes. Despite exhibiting a significant increase of the 6A7 epitope exposure, substituted mutants remain limited in their ability to form large oligomers, suggesting that they high capacity to promote apoptosis in cells was more related to a high content than to an increased ability to form large pores in the outer mitochondrial membranes.

Details

Language :
English
ISSN :
2234943X
Volume :
12
Database :
Directory of Open Access Journals
Journal :
Frontiers in Oncology
Publication Type :
Academic Journal
Accession number :
edsdoj.64d6b3d2d0bf4495bb4bb1c2dca1ceac
Document Type :
article
Full Text :
https://doi.org/10.3389/fonc.2022.1068994